Blood Flow Restriction Training in Patients With Shoulder Pain
Launched by HACETTEPE UNIVERSITY · Apr 2, 2020
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
In recent years, one of the popular applications used for muscle hypertrophy and strength training is low-intensity exercise training called Blood Flow Restriction Training. This exercise training has been shown to allow the benefits of high-intensity training at a much lower intensity. Given the light-load nature and strengthening capacity of this training, it can provide an effective clinical rehabilitation stimulus without the high levels of joint stress. It is suggested that it will be a useful exercise alternative especially in individuals who cannot tolerate high-intensity exercise. E...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteer to participate in the study
- • Being 18-45 years
- • Unilateral rotator cuff related shoulder pain
- • No symptoms in the contralateral shoulder
- Exclusion Criteria:
- • Diagnosis of hypertension, cardiovascular diseases, peripheral vascular diseases, deep vein thrombosis history, neurological diseases, systemic inflammation, obesity, diabetes
- • Subject has cancer
- • Pregnancy status
- • Cervical symptoms
- • Shoulder range of motion limitation
- • Injection to the shoulder joint in the last 6 months
- • Individuals who do not agree to participate in the study
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Levent Ozcakar, PhD,Prof.
Principal Investigator
Hacettepe University
Irem Duzgun, PhD,Prof.
Principal Investigator
Hacettepe University
Dilara Kara, MSc.
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials